Article Information
History
- October 26, 2021.
Article Versions
- You are currently viewing Version 1 of this article (October 26, 2021 - 17:55).
- View Version 2, the most recent version of this article.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- Karen Colwill, (PhD)1,
- Yannick Galipeau, (BSc)2,
- Matthew Stuible, (PhD)3,
- Christian Gervais, (BSc)3,
- Corey Arnold, (PhD)2,
- Bhavisha Rathod, (BSc)1,
- Kento T. Abe, (BSc)1,4,
- Jenny H. Wang, (MSc)1,
- Adrian Pasculescu, (PhD)1,
- Mariam Maltseva, (MSc)2,
- Lynda Rocheleau, (BSc)2,
- Martin Pelchat, (PhD)2,5,
- Mahya Fazel-Zarandi1,
- Mariam Iskilova, (MSc)1,
- Miriam Barrios-Rodiles, (PhD)1,
- Linda Bennett, (BSc)1,
- Kevin Yau, (MD)6,
- François Cholette, (MPH)7,
- Christine Mesa, (MSc)7,8,
- Angel X. Li, (MSc)9,
- Aimee Paterson, (MSc)9,
- Michelle A. Hladunewich, (MD, MSc)6,
- Pamela J. Goodwin, (MD)1,10,
- Jeffrey L. Wrana, (PhD)1,4,
- Steven J. Drews, (PhD)11,
- Samira Mubareka, (MD)12,13,
- Allison J. McGeer, (MD)9,14,
- John Kim, (PhD)8,
- Marc-André Langlois, (PhD)2,5,*,
- Anne-Claude Gingras, (PhD)1,4,* and
- Yves Durocher, (PhD)3,*
- 1Lunenfeld-Tanenbaum Research Institute at Mount Sinai Hospital, Sinai Health, Toronto, ON, Canada
- 2Department of Biochemistry, Microbiology, and Immunology, University of Ottawa, Ottawa, Canada
- 3Mammalian Cell Expression, Human Health Therapeutics Research Centre, National Research Council Canada, Montréal, QC, Canada
- 4Department of Molecular Genetics, University of Toronto, Toronto, ON, Canada
- 5The Centre for Infection, Immunity, and Inflammation, University of Ottawa, Ottawa, Canada
- 6Division of Nephrology, Department of Medicine, Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada
- 7National Microbiology Laboratory, Public Health Agency of Canada, Winnipeg, MB, Canada
- 8Department of Medical Microbiology and Infectious Diseases, University of Manitoba, Winnipeg, MB
- 9Lunenfeld-Tanenbaum Research Institute and Department of Microbiology, at Mount Sinai Hospital, Sinai Health, Toronto, ON, Canada
- 10Department of Medicine, University of Toronto, Toronto, ON, Canada
- 11Canadian Blood Services, Microbiology, Donation Policy and Studies, Edmonton, AB & Department of Laboratory Medicine and Pathology, Division of Diagnostic and Applied Microbiology, University of Alberta, Edmonton, AB, Canada
- 12Department of Laboratory Medicine and Molecular Diagnostics, Division of Microbiology, Sunnybrook Health Sciences Centre; Biological Sciences, Sunnybrook Research Institute; and Division of Infectious Diseases, Sunnybrook Health Sciences Centre, Toronto, ON, Canada
- 13Department of Laboratory Medicine and Pathology, University of Toronto, Toronto, ON, Canada
- 14Institute of Health Policy, Management and Evaluation, University of Toronto, Toronto, ON, Canada
- ↵*Correspondence: Marc-André Langlois: langlois{at}uottawa.ca, Anne-Claude Gingras: gingras{at}lunenfeld.ca, Yves Durocher: yves.durocher{at}cnrc-nrc.gc.ca
Posted October 26, 2021.
A “Made-in-Canada” serology solution for profiling humoral immune responses to SARS-CoV-2 infection and vaccination
